BBZA.DE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:35):

Stats
Today's Volume	19 370.00
Average Volume	24 340.00
Market Cap	2.27B
EPS	€0 ( 2023-10-20 )
Last Dividend	€2.85 ( 2023-03-27 )
Next Dividend	€0 ( N/A )
P/E	-10.62
ATR14	€0.101 (0.24%)

Volume Correlation

Long: 0.11 (neutral)

Short: -0.30 (neutral)

Signal:(45.459) Neutral

BB Biotech AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BB Biotech AG Correlation - Currency/Commodity

0.80
( strong )

0.58
( weak )

0.00
( neutral )

-0.49
( neutral )

-0.16
( neutral )

-0.80
( strong negative )

BB Biotech AG Financials

Annual	2023
Revenue:	€-199.57M
Gross Profit:	€-199.57M (100.00 %)
EPS:	€-3.77

Q4	2023
Revenue:	€111.17M
Gross Profit:	€111.17M (100.00 %)
EPS:	€1.990

Q3	2023
Revenue:	€-40.70M
Gross Profit:	€-40.70M (100.00 %)
EPS:	€-0.890

Q2	2023
Revenue:	€-4.68M
Gross Profit:	€-4.68M (100.00 %)
EPS:	€-0.250

Financial Reports:

No articles found.

BB Biotech AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€2.85 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

BB Biotech AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.13 - average (38.26%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€3.60	2021-03-22
Last Dividend	€2.85	2023-03-27
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	€10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	1.3	--
Div. Sustainability Score	5.13
Div.Growth Potential Score	0
Div. Directional Score	2.55	--

Next Divdend (Est)
(2024-12-31)

€0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

1.30

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
IE2A.F	Ex Dividend Junior	2023-05-02	Sporadic	0.00%
SNW.DE	Ex Dividend Knight	2023-05-30	Annually	0.00%
DAM.DE	Ex Dividend Knight	2023-05-10	Annually	0.00%
LIN.DE	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
4AB.DE	Ex Dividend Knight	2023-10-12	Quarterly	0.00%
UNVB.DE	Ex Dividend Knight	2023-08-03	Quarterly	0.00%
ENL.DE	Ex Dividend Knight	2023-07-24	Semi-Annually	0.00%
NOA3.DE	Ex Dividend Knight	2023-10-23	Semi-Annually	0.00%
ALD.DE	Ex Dividend Knight	2023-08-10	Quarterly	0.00%
ZIL2.DE	Ex Dividend Junior	2023-05-17	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	1.109	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0783	1.200	-2.61	-3.13	[0 - 0.3]
returnOnEquityTTM	-0.0911	1.500	-2.12	-3.18	[0.1 - 1]
payoutRatioTTM	-0.757	-1.000	-7.57	7.57	[0 - 1]
currentRatioTTM	0.00742	0.800	-4.96	-3.97	[1 - 3]
quickRatioTTM	8.40	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.00160	1.500	-1.102	-1.653	[0.2 - 2]
debtRatioTTM	0.231	-1.500	6.15	-9.22	[0 - 0.6]
interestCoverageTTM	-35.41	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.98	2.00	8.01	10.00	[0 - 20]
debtEquityRatioTTM	0.262	-1.500	8.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	1.103	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.358	1.000	9.12	9.12	[0.2 - 2]
assetTurnoverTTM	-0.0706	0.800	-3.80	-3.04	[0.5 - 2]
Total Score				5.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-10.98	1.000	-1.210	0	[1 - 100]
returnOnEquityTTM	-0.0911	2.50	-1.365	-3.18	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
dividendYielPercentageTTM	4.98	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
payoutRatioTTM	-0.757	1.500	-7.57	7.57	[0 - 1]
pegRatioTTM	-0.0604	1.500	-3.74	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-1.172	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.0226

BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.